Journals / Turkish Journal of Gastroenterology / 2020 / Cilt: 31 - Sayı: 12

Expression of lncRNA MSC-AS1 in hepatocellular carcinoma cell lines and its effect on proliferation, apoptosis, and migration

Pages
860–867
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The rate of wound healing and the number of invasion cells in the MSC-AS1 siRNA group were significantly lowerthan that in the blank and NC-siRNA groups.Conclusion: MSC-AS1 was upregulated in HCC cells, and the downregulation of MSC-AS1 could inhibit cell proliferation, migration, andinvasion and promote apoptosis of HCC cells.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: This study aimed to explore the expression of long non-coding RNA MSC-AS1 in hepatocellular carcinoma (HCC)cells and its effect on the proliferation, migration, and apoptosis of HCC cells.Materials and Methods: The expression of MSC-AS1 in HCC cell lines BEL7402, SMMC7721, Huh7, HepG2, MHCC97-H, and normalhepatocyte line L02 was detected by reverse transcriptase polymerase chain reaction.
📊
Key Findings & Data:The HCC cells were divided into blank, negativecontrol (NC)–small interfering RNA (siRNA) (transfected with negative siRNA), and MSC-AS1 siRNA (transfected with MSC-AS1 siRNA)groups.
💡
Conclusion & Impact:The rate of wound healing and the number of invasion cells in the MSC-AS1 siRNA group were significantly lowerthan that in the blank and NC-siRNA groups.Conclusion: MSC-AS1 was upregulated in HCC cells, and the downregulation of MSC-AS1 could inhibit cell proliferation, migration, andinvasion and promote apoptosis of HCC cells.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: This study aimed to explore the expression of long non-coding RNA MSC-AS1 in hepatocellular carcinoma (HCC)cells and its effect on the proliferation, migration, and apoptosis of HCC cells.Materials and Methods: The expression of MSC-AS1 in HCC cell lines BEL7402, SMMC7721, Huh7, HepG2, MHCC97-H, and normalhepatocyte line L02 was detected by reverse transcriptase polymerase chain reaction. The HCC cells were divided into blank, negativecontrol (NC)–small interfering RNA (siRNA) (transfected with negative siRNA), and MSC-AS1 siRNA (transfected with MSC-AS1 siRNA)groups. Cell counting kit-8 and colony formation assays were used to determine the proliferation, and cell apoptosis, migration, andinvasion were detected by flow cytometry, wound healing, and transwell assays, respectively. Western blot was used to detect the expression of related proteins.Results: The expression of MSC-AS1 in HCC cell lines was significantly higher than that in L02. In the MSC-AS1 siRNA group, the proliferation and colony formation of HCC cells were inhibited, whereas the apoptosis rate was significantly higher than that in the blankand NC-siRNA groups. The rate of wound healing and the number of invasion cells in the MSC-AS1 siRNA group were significantly lowerthan that in the blank and NC-siRNA groups.Conclusion: MSC-AS1 was upregulated in HCC cells, and the downregulation of MSC-AS1 could inhibit cell proliferation, migration, andinvasion and promote apoptosis of HCC cells.

🔖

Cite This Article

KOU, X., ZHU, J., XIE, X., HAO, M., ZHAO, Y. (2020). Expression of lncRNA MSC-AS1 in hepatocellular carcinoma cell lines and its effect on proliferation, apoptosis, and migration. Turkish Journal of Gastroenterology, Cilt: 31 - Sayı: 12, 860–867. https://ajindex.com/articles/409239

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016; 66: 115-32
  2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424
  3. Kopp F, Mendell JT. Functional Classification and Experimental Dissection of Long Noncoding RNAs. CELL 2018; 172: 393-407
  4. Fang L, Sun J, Pan Z, et al. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IkappaB. Am J Physiol Gastrointest Liver Physiol 2017; 313: G150-6
  5. Wang F, Ying HQ, He BS, et al. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget 2015; 6: 7899-917
  6. Ding LJ, Li Y, Wang SD, et al. Long Noncoding RNA lncCAMTA1 Promotes Proliferation and Cancer Stem Cell-Like Properties of Liver Cancer by Inhibiting CAMTA1. INT J MOL SCI 2016; 17: 1617
  7. Wang X, Sun W, Shen W, et al. Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis. J HEPATOL 2016; 64: 1283-94
  8. Liu J, Wang Q, Zhang R, Zhang C, Lin J, Huang X. Identification of LINC01279 as a cell cycleassociated long noncoding RNA in endometriosis with GBA analysis. MOL MED REP 2018; 18: 3850-8
  9. Gu JX, Zhang X, Miao RC, et al. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. World J Gastroenterol 2019; 25: 220-32
  10. Waly RS, Yangde Z, Yuxiang C. Hepatocellular carcinoma: focus on different aspects of management. ISRN Oncol 2012; 2012: 421673
  11. Yu WB, Rao A, Vu V, Xu L, Rao JY, Wu JX. Management of centrally located hepatocellular carcinoma: Update 2016. World J Hepatol 2017; 9: 627-34
  12. Schmitt AM, Chang HY. Long Noncoding RNAs in Cancer Pathways. Cancer Cell 2016; 29: 452-63
  13. Zhan M, He K, Xiao J, et al. LncRNA HOXA11-AS promotes hepatocellular carcinoma progression by repressing miR-214-3p. J Cell Mol Med 2018; 22: 3758-67
  14. Liu B, Li J, Liu X, et al. Long non-coding RNA HOXA11-AS promotes the proliferation HCC cells by epigenetically silencing DUSP5. Oncotarget 2017; 8: 109509-21
  15. Guo J, Hao C, Wang C, Li L. Long noncoding RNA PVT1 modulates hepatocellular carcinoma cell proliferation and apoptosis by recruiting EZH2. Cancer Cell Int 2018; 18: 98
  16. Xiong H, Ni Z, He J, et al. Lnc